Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 583,724 shares at $13.12 ($7.8M) on 2021-02-16, disclosed to the SEC on 2021-02-16.
Open-market sale of $7.8M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.82 | 69,127 | $955K | 12.3% |
| 2 | $13.82 | 69,127 | $955K | 12.3% |
| 3 | $12.96 | 77,938 | $1.0M | 13.0% |
| 4 | $12.96 | 77,938 | $1.0M | 13.0% |
| 5 | $13.77 | 33,391 | $460K | 5.9% |
| 6 | $13.77 | 33,391 |
| $460K |
| 5.9% |
| 7 | $13.12 | 111,406 | $1.5M | 18.8% |
| 8 | $13.12 | 111,406 | $1.5M | 18.8% |
| Total | $13.32 avg | 583,724 | $7.8M | 100% |
| Filing → |
| ORGO | SELL | 2024-12-09 | $423K | — | Filing → |
| ORGO | SELL | 2022-06-03 | $2.7M | — | Filing → |
| ORGO | SELL | 2022-05-31 | $2.6M | — | Filing → |